Search results (1320)
« Back to PublicationsSupplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Figure from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Table from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Table from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Table from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Supplementary Table from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
Cheng VWT. et al, (2023)
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
Sallman DA. et al, (2023), J Clin Oncol
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis.
Mascarenhas J. et al, (2023), J Clin Oncol